Transcriptional activation of CYP2C, MxA and Fas in sudden infant death syndrome

International Journal of Molecular Medicine

Volumn 3, Issue 1, 1999, Pages 33-39

  Beurton, Fadela ^a   Gueret, Gildas ^b   Horisberger, Michel ^a   Cheron, Gerard ^c   Cresteil, Thierry ^d  

^a INSERM   (France)

^b CIBA GEIGY LTD   (Switzerland)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

CYP2C; Fas; Intcrferon ; MxA; Sudden infant death syndrome

Indexed keywords

ALPHA INTERFERON; CARRIER PROTEIN; CYP2C18 PROTEIN, HUMAN; CYP2C19 PROTEIN, HUMAN; CYP2C9 PROTEIN, HUMAN; CYTOCHROME P450; FAS ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; IFIT1 PROTEIN, HUMAN; IFIT2 PROTEIN, HUMAN; MIXED FUNCTION OXIDASE; MYXOVIRUS RESISTANCE PROTEINS; PROTEIN; RNA; STEROID 16ALPHA MONOOXYGENASE; STEROID MONOOXYGENASE; UNSPECIFIC MONOOXYGENASE;

ADULT; ARTICLE; CHROMOSOME MAP; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY; LIVER; LUNG; METABOLISM; NEWBORN; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUDDEN INFANT DEATH SYNDROME; TISSUE DISTRIBUTION; TRANSACTIVATION;

ADULT; ANTIGENS, CD95; ARYL HYDROCARBON HYDROXYLASES; CARRIER PROTEINS; CHROMOSOME MAPPING; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GTP-BINDING PROTEINS; HUMANS; INFANT, NEWBORN; INTERFERON-ALPHA; KIDNEY; LIVER; LUNG; MIXED FUNCTION OXYGENASES; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES; SUDDEN INFANT DEATH; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS);

EID: 0032608677     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.1.33     Document Type: Article

References (47)

1. KIonoff-Cohen H: Sleep position and sudden infant death syndrome in the United States. Epidemiology 8: 327-329, 1997.
2. Julius SA: There is still seasonality in sudden infant death syndrome in England and Wales. J Epidemiol Community Health 51: 101-102, 1997.
3. Hoffman HJ and Peterson DR: Sudden infant death syndrome ' and maternal smoking. Am J Public Health 82: 1380-1382, 1992.
4. Ponsorby ALB, Dwyer T, Gibbons LE, Cochranc JA and Wyang YG: Factors potentiating the risk of sudden infant death syndrome associated with the prone position. N Engl J Med 329: 377-382, 1993.
5. Hoffman HJ and Hillman LS: Epidemiology of the sudden infant death syndrome: maternal, neonatal and postnconatal risk factors. Clin Perinatol 19: 717-737, 1992.
6. Howat WJ, Moore IE, Judd M and Roche WR: Pulmonary immunopathology of sudden infant death syndrome. Lancet 343: 1390-1392, 1994.
7. An SF, Gould S, Keeling JW and Fleming KA: Role of respiratory viral infection in SIDS: detection of viral nucleic acid by in situ hybridization. J Pathol 171: 271-278, 1993.
8. Bajanowski T, Wiegand P, Cecchi R, Pring-Akerblom P, Adrian T, Jorch G and Brinkmann B: Detection and significance of adcnoviruscs in case of sudden infant death. Virchows Arch 428: 113-118, 1996.
9. Howatson AG: Viral infection and a intcrferon in SIDS. J Clin Patliol 45: 25-28, 1992.
10. Helweg-Larsen K and Garde E: Sudden natural death in children. A review of forensic autopsy protocols in cases of sudden death between the ages of one and five years, 1982-1991, with a special view to sudden unexplained death. Acta Paediatr 82: 975-978, 1993.
11. Lundemose JB, Smith H and Sweet C: Cytokine release from human peripheral blood leucocyte incubated with endotoxin with and without prior infection with influenza virus: relevance to the sudden infant death syndrome. Int J Exp Pathol 74: 291-297, 1993.
12. Blackwell CC, Weir DM and Busutti A: Infectious agents, the inflammatory responses of infants and sudden infant death syndrome (SIDS). Mol Med Today 1: 72-78, 1995.
13. Vege A, Rogrum TO, Scott H, Aasen AU and Sangstad OD: SIDS cases have increased levels of interleukin 6 in cerebrospinal fluid. Acta Paediatr 84: 193-196, 1995.
14. Lindgren C and Grögard J: Reflex apnoea response and inflammatory mediators in infants respiratory tract infection. Acta Paediatr 85: 798-803, 1996.
15. Trcluyer JM, Cheron G, Sonnier M and Cresteil T: Cytochrome P450 expression in sudden infant death syndrome. Biochem Pharmacol 52: 497-504, 1996.
16. Daikh BE, Lasker JM, Raucy JL and Koop DR: Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J Pharmacol Exp Ther 271: 1427-1433, 1994.
17. Leo MA, Lasker JM, Raucy JL, Kim CI, Black M and Lieber CS: Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch Biochem Biophys 269: 305-312, 1989.
18. Goldstein JA and De Morais SMF: Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4: 285-299, 1994.
19. Gross DS and Garrard WT: Nuclease hypersensitive sites in chromatin. Annu Rev Biochem 57: 159-197, 1988.
20. Lafage M, Clauss I, Couez D, Simonetti J, Wathelet MG and Huez G: The intcrferon- and virus-inducible IFI56K and IFI54K genes are located on human chromosome 10 at bands q23-q24. Genomics 3: 458-460, 1992.
21. Inoue K, Inazawa J, Suzuki Y, Shimada T, Yamazaki H, Guengerich FP and Abe T: Fluorescence in situ hybridization analysis of chromosomal localization of three cytochrome P450 2C genes (CYP2C8, 2C9 and 2C10) at 10q24.1. Jpn J Hum Genet 39: 337-343, 1994.
22. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA and Nagata S: The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Irnmunol 148: 1274-1279,1992.
23. Treluyer JM, Gueret G, Cheron G, Sonnier M and Cresteil T: Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in vivolin vitro correlation and inducibility. Pharmacogenetics 7: 441-452, 1997.
24. Cresteil T, Flinois JP, Pfister A and Leroux JP: Effect of microsomal preparations and induction on cytochrome P450-dependent monooxygenases in fetal and neonatal rat liver. Biochem Pharmacol 28: 2057-2063, 1979.
25. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
26. Horisberger MA and Hochkeppel HK: IFN-α induced 78 kDa protein: purification and homologies with the murine Mx protein, production of monoclonal antibodies, and potentiation effect of IFN-γ. J Interferon Res 7: 331-343, 1987.
27. Wang P, Bcaune P, Kaminsky LS, Dannan GA, Kadlubar FF, Larrey D and Guengerich FP: Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 22: 5375-5383, 1983.
28. Moroy T, Eticmble J, Trepo C, Thiollais P and Buendia MA: Transcription of woodchuck hepatitis virus in the chronically infected liver. EMBO J 4: 1507-1514, 1985.
29. Funiya H, Meyer UA, Gelboin HV and Gonzalez FJ: Polymerase chain reaction-directed identification, cloning and quantification of human CYP2C18 mRNA. Mol Pharmacol 40: 375-382, 1991.
30. Wathelet MG, Moulschen S, Defilippi P, Cravador A, Collet M, Huez G and Content J: Molecular cloning, lull length sequence and preliminary characterization of a 56-kDa protein induced by human interferons. Eur J Biochem 155: 11-17, 1986.
31. Wathclct MG, Szpirer J, Nols CB, Clauss IM, De Wit L, Islam MQ, Lcvan G, Horisbergcr MA, Content J, Szpirer C and Huez GA: Cloning and chromosomal location of human genes induciblc by type I interferon. Somat Cell Mol Genet 14: 415-426, 1988.
32. Ged C, Umbenhauer DR, Bellcw TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS and Gucngerich FP: Characterization of cDNAs, mRNAs and proteins related to human liver microsomal cytochromc P450 (S)-mephcnytoin 4′-hydroxyIase. Biochemistry 27:6929-6940, 1988.
33. Romkes M, Faletto MB, Blaisdell JA, Raucy JL and Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 30: 3247-3255, 1991.
34. Ibeanu GC and Goldstein JA: Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry 34: 8028-8036, 1995.
35. Jung F, Richardson TH, Raucy JL and Johnson EF: Diazepam metabolism by cDNA expressed human 2C P450s. Drug Metab Dispos 25: 133-139, 1997.
36. Horisberger MA: Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J Virol 66: 4705-4709, 1992.
37. Goetschy JF, Zeller H, Content J and Horisberger MA: Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine MX gene, by interferons, double-stranded RNA, certain cytokines and viruses. J Virol 63: 2616-2622, 1989.
38. Horisberger MA and De Staritzky K: Expression and stability of the MxA protein in different tissues of mice, in response to interferon inducers or to influenza virus infection. J Interferon Res 9: 583-590, 1989.
39. Forster J, Schweizer M, Schumacher RF, Kaufmehl K and Lob S: MxA protein in infants and children with respiratory tract infection. Acta Pacdiatr 85: 163-167, 1996.
40. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH and Moller P: Constitutive and induced expression of APO-1 a new member of the nerve growth factor/tumor necrosis factor receptor superfamily in normal and ncoplastic cells. Lab Invest 69: 415-429, 1993.
41. Yano H, Fukuda K, Haramaki M, Momosaki S, Ogasawara S, Higaki K and Kojiro M: Expression of Fas and anti-Fas-mediatcd apoptosis in human hepatocellular carcinoma cell lines. J Hepatol 25: 454-464, 1996.
42. Hamazaki K, Gochi A, Matsubara N, Mori M and Orita K: Expression of Fas antigen and Bcl-2 protein in hepatocellular carcinoma. Acta Med Okayama 49: 227-230, 1995.
43. De Waziers I, Cugnene PH, Yang CS, Leroux JP and Beaune P: Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253: 387-394, 1990.
44. Meehan RR, Gosden JR, Rout D, Hastie ND, Friedberg T, Adesnik M, Buckland R, van Heyningen V, Fletvher J, Spurr NK, Sweeney J and Wolf CR: Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. Am J Hum Genet 42: 26-37, 1988.
45. De Morais SMF, Schwcikl H, Blaisdell J and Goldstein JA: Gene structure and upstream resulatory resions of human CYP2C9 and CYP2C18. Biochem Biophys Res Commun 194: 194-201, 1993.
46. Bluyssen HAR, Vlietstra RJ, Faber PW, Smit EME, Hagemeijer A and Trapman J: Structure, chromosome localization and regulation of expression of the intcrferon-regulated mouse Ifi54/fi56 gene family. Genomics 24: 137-148, 1994.
47. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K and Nebert DW: The P450 supcrfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA Cell Biol 12: 1-51, 1993.